EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46−0.07 (-2.77%)
Close on Nov 17, 2026Market cap $2.46MP/E –Yield –
EoCene r&d expenses
Research and development expenses are spending on new products and technology.
EoCene's R&D Expenses for the twelve months ending Dec 31, 2025 was $4.87M, up 63.6% year over year. For fiscal 2025 it was $4.87M, up 63.6% from the year before. Over ten years it grew -4.4% a year on average. The highest annual figure on record is $27.22M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.87M | +63.6% |
| FY2024 | Dec 31, 2024 | $2.98M | -16.5% |
| FY2023 | Dec 31, 2023 | $3.57M | -72.5% |
| FY2022 | Dec 31, 2022 | $13.00M | -52.3% |
| FY2021 | Dec 31, 2021 | $27.22M | +4.4% |
| FY2020 | Dec 31, 2020 | $26.08M | +43.5% |
| FY2019 | Dec 31, 2019 | $18.18M | +118.7% |
| FY2018 | Dec 31, 2018 | $8.31M | -13.9% |
| FY2017 | Dec 31, 2017 | $9.65M | -32.4% |
| FY2016 | Dec 31, 2016 | $14.27M | +87.1% |
| FY2015 | Dec 31, 2015 | $7.63M | +14.5% |
| FY2014 | Dec 31, 2014 | $6.66M | -7.5% |
| FY2013 | Dec 31, 2013 | $7.21M | +195.0% |
| FY2012 | Dec 31, 2012 | $2.44M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.78M | +66.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.10M | +184.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.09M | +103.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.06M | +30.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.07M | -58.4% |
| Q3 FY2024 | Sep 30, 2024 | $738.00K | -89.5% |
| Q2 FY2024 | Jun 30, 2024 | $534.00K | -89.3% |
| Q2 FY2023 | Jun 30, 2023 | $809.00K | -76.8% |
| Q2 FY2022 | Jun 30, 2022 | $2.58M | +33.0% |
| Q2 FY2021 | Jun 30, 2021 | $7.04M | +199.8% |
| Q2 FY2020 | Jun 30, 2020 | $4.97M | +47.9% |
| Q2 FY2019 | Jun 30, 2019 | $3.49M | +123.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.94M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.35M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.36M | – |
| Q2 FY2015 | Jun 30, 2015 | $1.56M | – |
See a number that looks wrong?